IL99169A - Medicinal products containing 4-methylthiazole - Google Patents

Medicinal products containing 4-methylthiazole

Info

Publication number
IL99169A
IL99169A IL9916991A IL9916991A IL99169A IL 99169 A IL99169 A IL 99169A IL 9916991 A IL9916991 A IL 9916991A IL 9916991 A IL9916991 A IL 9916991A IL 99169 A IL99169 A IL 99169A
Authority
IL
Israel
Prior art keywords
chloro
methylthiazole
hydroxyethyl
treatment
pharmaceutically acceptable
Prior art date
Application number
IL9916991A
Other languages
English (en)
Hebrew (he)
Other versions
IL99169A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL99169A0 publication Critical patent/IL99169A0/xx
Publication of IL99169A publication Critical patent/IL99169A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9916991A 1990-08-15 1991-08-12 Medicinal products containing 4-methylthiazole IL99169A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002659A SE9002659D0 (sv) 1990-08-15 1990-08-15 New pharmaceutical formulations

Publications (2)

Publication Number Publication Date
IL99169A0 IL99169A0 (en) 1992-07-15
IL99169A true IL99169A (en) 1995-10-31

Family

ID=20380161

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9916991A IL99169A (en) 1990-08-15 1991-08-12 Medicinal products containing 4-methylthiazole

Country Status (26)

Country Link
US (1) US5385921A (de)
EP (1) EP0619734B1 (de)
JP (1) JP3094077B2 (de)
AT (1) ATE164066T1 (de)
AU (1) AU657490B2 (de)
BG (1) BG97446A (de)
CA (1) CA2088775A1 (de)
CZ (1) CZ279586B6 (de)
DE (1) DE69129126T2 (de)
DK (1) DK0619734T3 (de)
ES (1) ES2114891T3 (de)
FI (1) FI930608A (de)
HU (1) HUT65821A (de)
IE (1) IE912818A1 (de)
IL (1) IL99169A (de)
IS (1) IS3743A7 (de)
LT (1) LT3978B (de)
LV (1) LV10921B (de)
NO (1) NO303447B1 (de)
NZ (1) NZ239329A (de)
PT (1) PT98688B (de)
RO (1) RO112994B1 (de)
RU (1) RU2093155C1 (de)
SE (1) SE9002659D0 (de)
SK (1) SK8793A3 (de)
WO (1) WO1992003134A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
CN103772313B (zh) * 2014-01-02 2015-10-14 郑桂富 一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) * 2020-10-26 2021-01-26 宜宾学院 油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825966A1 (de) * 1978-06-14 1980-01-03 Basf Ag Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
BG97446A (en) 1994-03-24
IS3743A7 (is) 1992-02-16
NZ239329A (en) 1994-11-25
CZ279586B6 (cs) 1995-05-17
EP0619734B1 (de) 1998-03-18
LTIP1714A (en) 1995-09-25
IL99169A0 (en) 1992-07-15
HU9300388D0 (en) 1993-04-28
LV10921A (lv) 1995-12-20
HUT65821A (en) 1994-07-28
SK8793A3 (en) 1993-07-07
PT98688A (pt) 1992-07-31
CZ16693A3 (en) 1994-02-16
SE9002659D0 (sv) 1990-08-15
LT3978B (en) 1996-06-25
RU2093155C1 (ru) 1997-10-20
NO930452L (no) 1993-02-09
JP3094077B2 (ja) 2000-10-03
FI930608A0 (fi) 1993-02-11
AU657490B2 (en) 1995-03-16
NO930452D0 (no) 1993-02-09
DE69129126D1 (de) 1998-04-23
AU8409291A (en) 1992-03-17
DK0619734T3 (da) 1998-10-05
NO303447B1 (no) 1998-07-13
WO1992003134A1 (en) 1992-03-05
DE69129126T2 (de) 1998-07-23
LV10921B (en) 1996-08-20
CA2088775A1 (en) 1992-02-16
EP0619734A1 (de) 1994-10-19
FI930608A (fi) 1993-02-11
ES2114891T3 (es) 1998-06-16
JPH06500097A (ja) 1994-01-06
PT98688B (pt) 1999-01-29
ATE164066T1 (de) 1998-04-15
IE912818A1 (en) 1992-02-26
RO112994B1 (ro) 1998-03-30
US5385921A (en) 1995-01-31

Similar Documents

Publication Publication Date Title
US7074826B2 (en) R-NSAID esters and their use
WO2016153948A1 (en) Combination therapy using enantiopure, oxy-substituted, deuterium-enriched 5-(benzyl)-5-deutero-thiazolidine-2, 4-diones for treatment of medical disorders
JP2009102334A (ja) 神経変性疾患治療剤
AU2007253899A1 (en) Compositions of R(+) and S(-) pramipexole and methods of using the same
US20240287098A1 (en) Compositions and methods for treating cancer
EP0619734B1 (de) Neue pharmazeutische formulierungen von 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol
EP3883918B1 (de) Rip1-inhibitoren
WO2017100703A1 (en) Ems analogues of lyn/src-tyrosine kinase inhibitors
WO2005116012A1 (ja) ピロリジン誘導体
EP0458892B1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration
JPH04503512A (ja) 新規な医薬用途
JPH0228113A (ja) 高尿酸血症改善・治療剤
CN116535361A (zh) 取代羟基嘧啶类黄嘌呤氧化酶抑制剂及其制法和药物用途
JPH05140094A (ja) 置換（アミノフエニル）ヘテロアリールエチルアミンのエナンチオマー
JPH02101095A (ja) 新規化合物および該化合物を有効成分とする糖鎖代謝酵素阻害剤
JPH04295479A (ja) 抗炎症剤
NZ259531A (en) Use of idazoxan and derivatives (2-(1,4-benzodioxan-2-yl)-2-imidazoline) to prepare medicaments to treat alzheimer-type diseases
MXPA96002577A (en) Treatment of arterioesclerosis and xant
JPH01180821A (ja) 肝疾患治療・予防剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)